The first Intercept Pharmaceuticals trade was made in Q1 2019. Since then Joel Greenblatt bought shares one more times and sold shares on two occasions. The investor sold all their shares in Q1 2020 and doesn't own any shares in Intercept Pharmaceuticals anymore.